InsuranceLetter

My letter to my insurance company. I based my letter from information from 3 letters I found on websites while searching! Feel free to use mine and change it to fit your needs!

                                                                                                                                                    Saturday, January 13, 2001

Dear Florida First Health Choice Plans, Inc.:

My name is Meghan DeFrancesco (member id#             ). I am 22 years old, a full-time college student, studying psychology. I also work part-time as a merchandiser! I have a wonderfully supportive Mom and Dad, one younger brother, 3 dogs and one cat. I am living in sunny (but HOT) Naples, Florida. I have lived in Naples all of my life, and am hoping to live here for many more years. See, for most people there would be an easy way to make sure they would live in Naples for many years, they just wouldn�t move! I don�t have that reassurance because although I might choose to live here, I might not live many more years in my current condition. See, I am morbidly obese. I want to live to be an old woman, not die before 30.
I have struggled with my excessive weight problems for as long as I can remember. For more than 10 years, I have tried every "diet," "health plan," "eating philosophy," and "life change" suggested by doctors, books, family, friends and health professionals. I would start a plan; follow it through for a few weeks, sometimes many months. I would always lose weight, sometimes, large amounts of weight, but I would reach a point when I would start gaining again. More often than not, I would gain back all the weight I lost, and usually a little more. This became a pattern that I could see and I was determined to change the pattern that had terrorized me my entire childhood and teen life. In 1996 I began diet pills, I have also tried fasting. I have probably spent an entire year�s worth of tuition on magazines to try new diets, exercises and philosophies. Of course, I have consulted with doctors, had my thyroid tested. I have documented a lot of what I have attempted which is included in this letter. I spared you all the little diets or theories I tried and I lost weight, but never could break the pattern of regaining the weight. Not only were these attempts unsuccessful, but incredibly costly as well.
My motivation to lose the weight was always new and different. Not only did I attempt to trick my body but my mind as well. To look like other teenagers, to fit into my dress for the prom, however, deep down I�ve always wanted to just be healthy and prevent medical problems. When I was younger and would fail at dieting, I always "had time" and would eventually try again. I was going to lose the weight before I was 15, then 20, and so on. Now, I am 22 and those health problems that are associated with morbid obesity are creeping into my life. I�ve noticed changes in my body that shouldn�t be there when a person is as young as I am. My grandfather died of a heart attack, I don�t want to also!
I am writing you to explain to you why you must approve my Gastric Bypass surgery for me. I am not requesting a Gastric Bypass for weight reduction reasons or even cosmetic reasons. I desperately need a Gastric Bypass for health reasons.
I have chronic pain from the base of my neck down to my lower back from the weight of my large breasts and body. With all the excess weight pulling on the discs in my back, it causes considerable pain and numbness. My legs constantly go numb while I am sitting because of all the weight. I can�t sit in a car for more then ten minutes without shooting pains in my leg that persist until a tingling numbness sets in. I cannot stand for a long period of time because my lower back hurts unbearably.
I have stress incontinence to some degree so that when I sneeze, cough, or laugh I must run to the bathroom. I am constantly short of breath, even when I so much as bend over to pick something up. I perspire easily, as soon as I do some sort of activity. I had a three-month period early in 200 when my blood pressure was high. Luckily, it went back to the normal (however still high) range, but can you see where this is going? I am on a downslide! I am starting to and already have some of the symptoms of major disorders. I want to stop this before I am so unhealthy I cannot lead what miniscule life I already have. I do not want to die.
I am currently being treated for depression. Social phobias require an extra amount of my treatment time. My therapist has been through years of weight loss plans with me and the results of weight returning, depression worsening, social phobia�s growing stronger. I have to take Topamax every day to function as a normal human being. This is a great cost to both you and I. With the loss of the weight, which is the stem of my health problems and depression, I should be able to lower the dose age of Topamax if not stop taking it completely, which would be wonderful for both of us. Please do not deny my chance to have a life. If there were any other way� we would have discovered it by now.
I believe that I have developed this disorder because of this ongoing weight loss and gain. I have been on medications and counseling to control my depression, but in my heart I know that I must have this surgery for my own sanity. I have tried every diet and pill that I can think of, and nothing has worked. If you fail to approve this surgery, I will be at my wit's end. There is nothing left for me to do after this except resign to the fact that this is the way I am. However, I know that somewhere, underneath all of this heaviness and hopelessness, a healthy me is waiting to come out.
As I sit here typing, my legs are going numb from the weight. I suffer from depression. I have been on medication for depression. As young as I am, and to have tried to lose weight and get healthy as many times, and for as many years as I have, I am devastated that, at this point, I weigh 281 pounds.
I began to research obesity and began to learn and understand a disease that I have. I learned that there are different stages of obesity: obese, severe obese, morbidly or very severe obese. People with a Body Mass Index (BMI) greater than 40 are in the stage, Morbidly Obese. My BMI is 51.1. Being at the highest stage of obesity, heart disease, cancer, diabetes, and death are inevitable; it is just a matter of time. My risk of heart failure is 208% greater than a person with a normal BMI. These are not "light weight" complications. I had to realize, these are fatal diseases. I learned that my being Morbidly Obese is a direct threat to my life. I also found in my research, that the National Institute of Health (NIH) has recognized that only 2% of people who try to lose weight, will lose it and keep it off for a period longer that five years. The NIH has published that surgery is the only permanent solution to keep weight off and avoid death and disease associated with obesity. This was very hard for me to believe at first, but then the more I researched and the more I educated myself, the more I realized it was true. After looking at my 10-year diet history, surgery is the only permanent solution to save my life.
Morbid obesity is an intensely stigmatizing physical disability. The Americans With Disability Act describes a disability as:
Physical or mental condition which impairs major life functions: Caring for oneself, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, sitting, standing, lifting, reaching, working.
Morbid Obesity affects 80% of these functions.
Like most afflicted with this disease, I have tried numerous organized weight reduction/fad diets and organizations, not limited to but including: Metabolife, Weight Watchers, and Atkins. I have taken some weight off but it is gained right back and then some. I cannot lose the weight any other way, except by the Gastric Bypass Surgery.
The surgery I am requesting is medically necessary to permanently get this weight off and eliminate the co-morbidities I already have and to eliminate the high risk of death that I am in.
Without this one surgery, I am looking at the possibility of multiple surgeries. A breast reduction to eliminate my chronic back pain; knee surgeries if my knees give out from the weight; bladder surgery if the incontinence goes further; and, psychotherapy and antidepressant drugs for my depression and anxiety. This does not include diseases yet to happen: diabetes, heart disease, and cancer. I do not like surgery. I do not want surgery, but if I had to choose one surgery or multiple surgeries, I would opt for the one.
Previous doctors and surgeons have recommended that this one surgery could improve and eliminate all my co-morbidities and eliminate the need for other surgeries and medications. It seems much more cost-effective to have this one surgery instead of many.
Please view everything sent to you as carefully as possible. It is so important to me to have this surgery. I am at a major health risk, not in a good mental health state, and I have no more money to be spent on all of these diets or pills that I have been doing for the last ten years. Please, I am begging you to help me. Not only will you be helping enrich my quality of life for my family and myself, you will literally be saving my life.
Your approving this surgery will be saving my life and you will be giving me a quality of life that I have never known. Thank you for you time in reading this lengthy letter. I have poured my heart into this letter, and I pray that you will read it and do what is right. Please give me my Gastric Bypass Surgery.
Thank you.
Best regards,
Meghan, Naples, Florida

Make up a spreadsheet or something for your Diet History and place it here.

Emotional and Therapeutic Recourses
I have been in therapy for years and have written out many weight loss plans (we don�t call them diets.) In the last year that we have been discussing weight loss surgery I have been keeping a journal on my eating habits, what is emotional about eating, what triggers I am susceptible to concerning my weight, my health and my family background individually and as a whole.
My therapist fully supports my decision to go through with weight loss surgery having discussed every issue possible that can and will come up as a result. Making sure that I have committed to this procedure as a life long effort to be a healthy woman.
Both my therapist and my family have committed with me to see this through and to be aware of the emotional issues that can arise both pre and post surgery. I have joined four support groups of people who are waiting or have already gone through weight loss surgery, one of these support groups is a real life monthly session, the others are online support through which I have met many wonderful people.   I also have the support of my three best friends, who have endeavored to find out as much about the surgery as I have, and will support me totally throughout this. This is my own decision however.
I don�t believe this will be easy. I do believe it has been one of the most difficult, life-altering decisions I have ever made and I have not made it lightly. It is a "last alternative" in a life long battle and I also see it as an opportunity to begin to break the cycle for me and it gives me the chance to have a real future.
I want the most out of life that it has to offer. With this surgery, you give me a chance to have all that and more. You give me a chance to experience life again. To walk across a room without tiring, to stand without pain, to bend over and pick something up and be able to breath while doing so. To be able to tie my shoes without having to find somewhere to sit that is low enough so I can reach my feet.
I hope this letter helps you to understand how very important this will be to myself but also to all those I love and who love me.
Co-morbidities
� Depression
� Acid Reflux
� Back and Neck Pain
� The beginnings of Stress Incontinence
� I had a three month period of High Blood Pressure
Family Medical Background
� Obesity - all family members on both my mother�s and my fathers side suffer from varying degrees of obesity, or the fight of obesity and related co-morbidities, including but not limited to diabetes, heart and artery disease, and many different cancers.
� Cervical Cancer- Maternal Grandmother
� Heart Failure � Maternal Grandfather
� Brain Tumor- Paternal Grandfather
� Heart Problems � Maternal Grandmother (Great-Aunt)
� High Blood Pressure � various degrees on both sides
The cost to treat these things is much greater than the cost of the gastric bypass surgery. Most all of these listed items can be attributed to both my mother and father, their fathers and mothers, those that are still with us.
Gastric Bypass Surgery
The Gastric Bypass is a tool to lose the weight. This tool will help me lose the weight permanently. This is a surgical procedure needed to treat my disease effectively. I do suffer from Severe Morbid Obesity, a disease classified by the National Institute of Health as being more than 20% above my ideal weight. This life long affliction has caused numerous serious health complications as I have mentioned above. Normal activities of living are restricted by my weight, I am so limited as to what I can do. My health is in extreme jeopardy and this surgery is a medical necessity. If I do not have, this surgery death will ultimately come sooner than it should. I am young (22 years old) I could have a long life ahead of me. The majority of my health problems can be corrected with this surgery that will save you money in the end. I urge you to reflect on my statements when you make your decision. Give me a second chance in life.

STATEMENT ON MORBID OBESITY
Morbid obesity is a chronic, lifelong, multifactorial, genetically-related disease of excessive fat storage with highly significant medical, psychological, social, physical and economic co-morbidities. As such, it also involves hereditary, biochemical, hormonal, environmental, behavioral, public health, and cultural elements.
Morbid obesity is, therefore, an extreme health hazard, which is rarely the result of an aberrant moral problem or addictive behavior. There is an extremely high incidence of failure to sustain even a 10 per cent long-term weight loss in morbidly obese patients with any form of non-operative treatment. Bariatric surgery, on the other hand, has been shown to be the most effective means to aid in management and prophylaxis of the life-threatening complications and severe degenerative problems of morbid obesity. It is indicated due to the ineffectiveness of non-operative treatment methods for morbid obesity, the high risk of untreated morbid obesity, and the safety and effectiveness of operative treatment. Safe, effective bariatric operative procedures increase the longevity and quality of life in morbidly obese patients. Such surgery is performed as treatment for the co-morbidities of morbid obesity. Weight loss, while an essential component of this process, is only incidental to these goals, as is any possible cosmetic outcome.
Patients with sleep apnea, obesity hyperventilation, cardiac failure, or other life-threatening complications may require emergency admission and care. An operation can then be planned at a time when the patient�s condition is stable with adequate cardio respiratory reserve.
Size discrimination condemns morbidly obese people to be excluded from access to medically necessary, quality care. Such discrimination and consequent exclusion is unacceptable. There is, therefore, no justification in requiring morbidly obese individuals to participate in long-term weight loss programs or requiring them to surmount comparable barriers as a prerequisite for approval of bariatric surgery, unless the surgeon�s judgment precludes same.
NIH Consensus Statements: Gastrointestinal Surgery for Severe Obesity
Abstract
The National Institutes of Health Consensus Development Conference on Gastrointestinal Surgery for Severe Obesity brought together surgeons, gastroenterologists, endocrinologists, psychiatrists, nutritionists, and other health care professionals as well as the public to address: the non-surgical treatment options for severe obesity, the surgical treatments for severe obesity and the criteria for selection, the efficacy and risks of surgical treatments for severe obesity, and the need for future research on and epidemiological evaluation of these therapies. Following 2 days of presentations by experts and discussion by the audience, a consensus panel weighed the evidence and prepared their consensus statement.
Among their findings, the panel recommended that (1) patients seeking therapy for severe obesity for the first time should be considered for treatment in a non-surgical program with integrated components of a dietary regimen, appropriate exercise, and behavioral modification and support, (2) gastric restrictive or bypass procedures could be considered for well-informed and motivated patients with acceptable operative risks, (3) patients who are candidates for surgical procedures should be selected carefully after evaluation by a multidisciplinary team with medical, surgical, psychiatric, and nutritional expertise, (4) the operation be performed by a surgeon substantially experienced with the appropriate procedures and working in a clinical setting with adequate support for all aspects of management and assessment, and (5) lifelong medical surveillance after surgical therapy is a necessity.
The full text of the consensus panel's statement follows.
Introduction
In a 1985 National Institutes of Health (NIH) consensus conference, the health implications of obesity were established as including increased risk for cardiovascular disease (especially hypertension), dyslipidemia, diabetes mellitus, gallbladder disease, increased prevalence�s and mortality ratios of selected types of cancer, and socioeconomic and psychosocial impairment.
Risk for morbidity and mortality accompanying obesity is proportional to the degree of overweight. A simple means to define overweight is by the body mass index (BMI): [weight (kilograms)/height (meters)^2]. The BMI associated with lowest mortality is between 20 and 25 kg/m:^2. Approximately 4 million Americans have BMI's between 35 and 40 kg/m:^2, and another 1.5 million have BMI's over 40 kg/m:^2. A BMI of 40 kg/m^2 is roughly equivalent to 100 pounds overweight for an average adult male. Persons at the highest risk of morbidity and mortality can be categorized as having "clinically severe obesity," a term that is preferred to "morbid obesity." Patients with severe obesity are potential candidates for treatment by surgical procedures.
The ultimate biologic basis of severe obesity is unknown, and specific therapy directed to it, therefore, is not available. This disorder, nevertheless, is accompanied by a reduction in life expectancy, which is due in large part to significant co-morbid associations in the form of metabolic abnormalities and several serious cardiopulmonary disorders. In addition, significant psychosocial and economic problems frequently are experienced by persons with severe obesity. These facts lend urgency to the effort to provide rational care for those seeking relief from effects of this condition.
A 1978 NIH consensus conference on surgery for obesity considered primarily intestinal (jejunoileal) bypass, which exerts its weight-loss effects through malabsorption, decreased food intake, and possibly other mechanisms. This operation was shown to be effective in some reported series of cases, but in many patients it was accompanied by serious complications. The 1978 conference highlighted the undesirable side effects of this operation, and its use has all but disappeared. In the past 10 to 15 years, other types of surgical procedures have been developed; these use reduction in gastric volume, gastric bypass, and other procedures. Mechanisms of weight loss with newer procedures, which may include both food aversion and malabsorption, have not been determined with certainty. Refinements in such procedures have led to reports of results superior to those seen with the earlier operation; however, side effects sometimes do occur, and in spite of weight loss, ideal body weight is rarely attained. The time has come to evaluate the objective evidence for these new surgical therapies.
To resolve questions relating to surgery for severe obesity, the National Institute of Diabetes and Digestive and Kidney Disease and the Office of Medical Applications of Research of the NIH convened a Consensus Development Conference March 25-27, 1991. After 2 days of presentations by experts in the field, a consensus panel representing the professional fields of surgery, general medicine, gastroenterology, nutrition, epidemiology, psychiatry, endocrinology, and including representatives from medical literature and the public, considered the evidence and agreed on answers to the questions that follow.
What Are the Nonsurgical Treatment Options for Severe Obesity and Their Consequences?
Nonsurgical approaches to treatment of clinically severe obesity include various combinations of low- or very low-calorie diets, behavioral modification, exercise, and pharmacologic agents. In addition to weight reduction regimens, co-morbid factors such as hypertension, dyslipidemia, and diabetes mellitus can be treated by usual medical methods. Published studies of medical approaches to the treatment of obesity include few reports or indications of efficacy in persons with clinically severe obesity. The potential efficacy of these approaches in persons with this degree of obesity, therefore, must be inferred from evidence of their efficacy in less obese persons.
Nonsurgical treatment of clinically severe obesity aims to create a caloric deficit sufficient to result in both permanent weight loss and reduction of weight-related risk factors or comorbidity. The specific amount of targeted weight loss is defined on a case-by-case basis and does not necessarily require reduction to ideal body weight.
Very low-calorie diets (VLCD's) have been widely publicized as having dramatic success in the treatment of clinically severe obesity. Typically, these diets contain 400 to 800 kilocalories per day with increased protein and minimal fat in a solid or liquid form. Significant weight reduction, for example 20 kg over 12 weeks, can be expected. However, in the absence of successful behavior modification, most patients regain their lost weight within 1 year. Thus, although VLCD's used under close medical supervision often are effective in short-term treatment of clinically severe obesity, these diets alone generally have not been successful for achieving permanent weight loss. Combining a VLCD with intensive behavioral modification may be more effective than a VLCD alone for treating the severely obese patient. Although data on the use of this approach are few, some evidence suggests that initial treatment with a VLCD followed by intensive behavioral modification may result in sustained weight loss in highly motivated patients with clinically severe obesity.
Behavioral modification is a therapeutic approach based on the assumption that habitual eating and physical activity behaviors must be relearned to promote long-term weight change. Behavioral treatment also can be combined with a lesser degree of caloric restriction, although evidence of long-term efficacy of this more conservative approach in persons with clinically severe obesity is lacking. Although increased physical activity is recommended as a component of weight-loss programs, the role of exercise in promoting and sustaining weight loss has never been established.
Experience with drug therapy for clinically severe obesity has been disappointing. Although pharmacologic studies with anorexigenic drugs suggest short-term benefit, prolonged and sustained weight loss has not been proved with these agents. Drugs such as amphetamines and thyroid derivatives are unsafe and unapproved.
Medical complications of rapid weight loss may occur and are usually treatable. Electrolyte abnormalities and cardiac arrhythmias during administration of VLCD's generally can be avoided or corrected by the inclusion of high-quality protein and frequent physician surveillance. Recent studies have recognized that rapid weight loss may be associated with a substantial incidence of gallstones. Although there are no specific complications of behavior therapy, failure to achieve sustained weight reduction may heighten the patient's sense of personal failure and decrease the motivation for further medical therapy.
Limited success has been achieved by various techniques that include medically supervised dieting and intensive behavior modification. During such a treatment program, co-morbidity factors such as hypertension, dyslipidemia, and diabetes mellitus can be treated by conventional medical therapy in the patient with clinically severe obesity. Although weight may be reduced acceptably, a major drawback to the non-surgical approach is failure to maintain reduced body weight in most patients. The possibility should not be excluded that the highly motivated patient can achieve sustained weight reduction by a combination of supervised low-calorie diets and prolonged, intensive behavior modification therapy.
What Are the Surgical Treatments and Criteria for Selection?
A number of operations have been tried and discarded as inefficacious or because of complications. Two procedures dominate practice in the early 1990's and have advanced beyond the experimental stage.
Vertical banded gastroplasty and related techniques consist of constructing a small pouch with a restricted outlet along the lesser curvature of the stomach. The outlet may be externally reinforced to prevent disruption or dilation.
Gastric bypass procedures involve constructing a proximal gastric pouch whose outlet is a Y-shaped limb of small bowel of varying lengths (Roux-en-Y gastric bypass).
Choosing between these procedures involves the surgeon's preference and consideration of the patient's eating habits. The somewhat greater weight loss after the gastric bypass procedure must be balanced against its higher risk of nutritional deficiencies, especially of micronutrients.
Biliary-pancreatic bypass includes a gastric restriction and diverts bile and pancreatic juice into the distal ileum. Experience with the procedure in the United States is limited.
Patient Selection
These surgical procedures are major operations with short- and long-term complications, some of which remain to be completely elucidated. There are insufficient data on which to base recommendations for patient selection using objective clinical features alone. However, while data accumulate, it may be possible in certain cases to consider surgery on the basis of limited information from the uncontrolled or short-term follow up studies available. A decision to use surgery requires assessing the risk-benefit ratio in each case. Those patients judged by experienced clinicians to have a low probability of success with non-surgical measures, as demonstrated for example by failures in established weight control programs or reluctance by the patient to enter such a program, may be considered for surgery.
A gastric restrictive or bypass procedure should be considered only for well-informed and motivated patients with acceptable operative risks. The patient should be able to participate in treatment and long-term follow-up.
Patients whose BMI exceeds 40 are potential candidates for surgery if they strongly desire substantial weight loss, because obesity severely impairs the quality of their lives. They must clearly and realistically understand how their lives may change after operation.
In certain instances less severely obese patients (with BMI's between 35 and 40) also may be considered for surgery. Included in this category are patients with high-risk co-morbid conditions such as life-threatening cardiopulmonary problems (e.g., severe sleep apnea, Pickwickian syndrome, and obesity-related cardiomyopathy) or severe diabetes mellitus. Other possible indications for patients with BMI's between 35 and 40 include obesity-induced physical problems interfering with lifestyle (e.g., joint disease treatable but for the obesity, or body size problems precluding or severely interfering with employment, family function, and ambulation).
Children and adolescents have not been sufficiently studied to allow a recommendation for surgery for them even in the face of obesity associated with BMI over 40.
What Are the Efficacy and Risks of Surgical Treatments for Obesity?
Issues of efficacy and risk in bariatric surgical procedures must be viewed in light of the fact that severe obesity is a chronic intractable disorder; any therapeutic program must, therefore, be lifelong.
While definitive therapy for severe obesity is not available, the surgical procedures in use can induce substantial weight loss, and this, in turn, may ameliorate co-morbid conditions. Since short- and intermediate-term effects observed in several studies may relate to long-term benefits, further application and investigation of these operations are justified. It must be kept in mind, however, that long-term results are of critical importance and must be delineated. Of special note, many patient cohorts studied to date are not representative of the distribution of race, ethnic and cultural factors, and socioeconomic status among the severely obese population.
Efficacy of Surgical Treatments for Obesity
Weight loss. The two major types of present operations for severe obesity are vertical banded gastroplasty and Roux-en-Y gastric bypass. The success rate for weight loss has been reported to be slightly higher with the Roux-en-Y operation. Substantial weight loss generally occurs, with the weight nadir occurring in 18 to 24 months. Some regain of weight is common by 2 to 5 years after operation. A third operation, biliopancreatic bypass, about which there are only limited data, also has been reported to produce weight loss but with a higher frequency of metabolic complications.
Co-morbid conditions
Weight reduction surgery has been reported to improve several co-morbid conditions such as sleep apnea and obesity-associated hypoventilation, glucose intolerance, frank diabetes mellitus, hypertension, and serum lipid abnormalities. Whether beneficial effects in the various metabolic disorders are maintained long enough to prevent end-organ damage (e.g., renal disease, stroke, myocardial infarction, and heart failure) is not known.
Psychosocial effects. Many patients report improvement in mood and other aspects of psychosocial functioning after these operative procedures. The degree to which these improvements are sustained is unknown.
Risk
Assessing the risks in the surgical treatment of obesity involves evaluating both perioperative and long-term complications. Available published series report that the immediate operative mortality rate for both vertical banded gastroplasty and Roux-en-Y gastric bypass is relatively low. On the other hand, morbidity in the early postoperative period, i.e., wound infections, dehiscence, leaks from staple line breakdown, stomal stenosis, marginal ulcers, various pulmonary problems, and deep thrombophlebitis in the aggregate, may be as high as 10 percent or more. In the later postoperative period, other problems may arise and may require reoperation. These are pouch and distal esophageal dilation, persistent vomiting (with or without stomal obstruction), cholecystitis, or failure to lose weight. Moreover, mortality and morbidity rates with reoperation are higher than those of primary operations.
In the long term, micronutrient deficiencies, particularly of vitamin B[sub12] foliate, and iron, are common after gastric bypass and must be sought and treated. Another potential result of this operation is the so-called "dumping syndrome," which is characterized by gastrointestinal distress and other symptoms. Occasionally, these symptoms may not respond to conservative measures and may be troublesome to the patient.
Many data suggest that deficient nutrition in pregnancy carries with it a high risk of fetal damage or loss. This is of particular concern because as many as 80 percent of patients having weight reduction surgery are women of childbearing age. In view of the uncertain frequency and effects on fetal development of rapid weight loss, micro- or macronutrient deficiency, or other metabolic sequelae of these procedures, secure birth control methods should be provided for these patients during this period of weight loss. They should be informed that maternal malnutrition may impair normal fetal development. Women who become pregnant after these surgical procedures need special attention from the clinical care team. The increased nutritional requirements for energy, protein, and specific micronutrients as well as the normal need for weight gain during pregnancy must be emphasized as part of the obstetrical management of these patients.
Quality-of-life considerations in patients undergoing surgical treatment for obesity must be considered, as there must be reorientation and adjustment to the side effects of surgery and the effect of a changing body image. Euphoria can be seen in patients during the early postoperative period. Some patients, however, may experience significant late postoperative depression. Some patients have depressive symptoms that are not improved by surgically induced weight loss.

What Specific Recommendations Can Be Made for the Treatment of Severe Obesity?
Decisions on what therapy to recommend to patients with clinically severe obesity should depend on their wishes for outcomes, on the physician's judgment of the urgency of the need for therapy, and on the physician's judgment of possible options for therapy and their probable efficacy.
Patients seeking therapy for the first time should be evaluated by a knowledgeable physician and provided with sufficient information on which to make a reasonable choice for therapy. In most cases, patients should first be considered for treatment in a nonsurgical program with integrated components of a dietary regimen, appropriate exercise, and behavioral support and modification. Possible comorbidities such as hypertension and diabetes should be sought and treated if not already under treatment. The desired outcomes may vary among patients and include such indices as a gain in the quality of life as judged by the patient, reduction of hypertension, and amelioration of glucose intolerance. A judgment of failed nonsurgical therapy should be followed by a decision for nonsurgical therapy in a different kind of program or with a different therapist, for no further therapy if significant comorbidities do not exist, or for surgical therapy.
Patients who are candidates for the surgical procedures reviewed during this conference should be selected carefully after evaluation by a multidisciplinary team with access to medical, surgical, psychiatric, and nutritional expertise. Patients should have an opportunity to explore with the physician any previously unconsidered treatment options and the advantages and disadvantages of each. The need for lifelong medical surveillance after surgical therapy should be made clear. With all of these considerations, the patient should be helped to arrive at a fully informed, independent decision concerning his or her therapy.
A decision for surgical therapy should be reached only after assessment of the probability that the patient will be able to tolerate surgery without excessive risk and to comply adequately with the postoperative regimen. There must be full discussion with the patient of the probable outcome of the surgery, of the probable extent to which it will eliminate the patient's problems, of the compliance that will be needed in the postoperative regimen, and of the possible complications from the surgery, both short- and long-term. Women with reproductive potential would be well advised to avoid pregnancy until weight has stabilized postoperatively and potential micronutrient deficiencies have been identified and treated.
The operation should be carried out by a surgeon substantially experienced with the appropriate procedures and working in a clinical setting with adequate support for all aspects of perioperative management and assessment. Postoperative care, nutritional counseling, and surveillance should continue for an indefinitely long period. The surveillance should include the monitoring of indices of inadequate nutrition and of amelioration of any preoperative disorders such as diabetes, hypertension, and dyslipidemia. The monitoring should include not only indices of macronutrients but also of mineral and vitamin nutrition.
What Are the Future Directions for Basic Science, Clinical Research, and Epidemiological Evaluation of Therapy?
The panel recognized the need to develop safe and effective means to treat patients with clinically severe obesity. In the view of the panel, none of the available therapies, including surgery, has been adequately evaluated. For this reason, it is recommended that centers be developed that can manage patients with clinically severe obesity, using a multidisciplinary approach, and, at the same time, can enter these patients into controlled investigations with long-term follow up. The research will need to involve a team that includes professionals trained in fields such as epidemiology, nutrition, surgery, general medicine, gastroenterology, cardiovascular-pulmonary medicine, psychiatry, and endocrinology. Only if in-depth investigations are carried out over long periods will needed information be obtained to care for obese patients more effectively in the future.
A series of issues arose during the conference that need additional investigation. These issues include the following:
The balance of efficacy and risk between surgical treatment and nontreatment or alternative treatments of severe obesity is difficult to evaluate with available information. Lacking are studies that use well-defined groups of subjects and standard protocols, with adequate power to define long-term outcomes. Nevertheless, the current reports from case series are sufficiently encouraging to indicate that well-organized clinical trials that address the critical issues surrounding surgical procedures are now in order.
A better vocabulary and nomenclature are critically needed to define clearly terms related to obesity, especially terms defining outcomes. These will improve communication between investigators.
A definition of the natural history of severe obesity is required that can serve as a baseline to evaluate the long-term effects of any form of therapy.
Various surgical procedures should be compared for complication rates, weight loss, long-term weight maintenance, and improvement in secondary complications of obesity.
Several specific issues were identified for better definition of the efficacy and risks of surgical therapy for severe obesity.
The mechanisms whereby surgical treatment produces weight reduction (i.e. malabsorption of nutrients, food aversion, decreased intake, altered metabolism) deserve further investigation.
Further investigation is needed of mechanisms whereby comorbidity factors are reduced by these surgical procedures.
The effects of surgical therapy should be defined in various subgroups stratified for gender, age, ethnicity, socioeconomic status, comorbidity, and fat distribution.
The effects of surgical treatment of mothers on their developing fetuses and whether it is safe for women to get pregnant after such operations must be determined.
Better statistical reporting of surgical results is urgently needed for clearer assessments of outcomes.
In addition, more effective alternate forms of weight-reduction therapy need to be developed and evaluated. Specifically, the following needs were identified:
Development of more effective behavioral techniques for producing long-term changes in eating and exercise behaviors is needed. Further, there is a need to determine the types of behavioral strategies that are most effective in treating various subgroups of overweight populations and to define the roles of physician, clinical psychologist, and dietitian in the behavioral approach.
Research is needed on how best to maintain weight reduction for a long term, with clarification of the roles of reduced caloric intake and increased energy expenditure (e.g., exercise). Consideration should be given to use of combined approaches, for example, low-calorie diets, behavior therapy, and drug therapy.
The potential for pharmacologic therapy needs further evaluation. The possibility that long-term drug therapy can be used successfully deserves exploration. Especially important are efficacy of therapy, long-term safety, and enhanced efficacy of drugs in combination.
One of the key problems in evaluating the current reports of case series in surgical therapy is the lack of standards for comparison. The present practice is to compare postoperative indicators of comorbidity to the same patient's own preoperative status. Although this approach may give some useful information on short-term effects of surgical therapy, it is insufficient for evaluation of long-term effects and of survival. An alternative approach for evaluating surgical therapy is to compare levels of morbidity and mortality in the surgical group with an appropriate comparison group. The establishment of a meaningful comparison group presents a challenge to future research.
Evaluation of the psychosocial changes that occur during weight reduction is needed. Standardized, reliable, and valid questionnaires and structured interviews should be developed to evaluate the patient's expectations about changes and the psychosocial changes they actually experience during weight loss and maintenance.